Transfusion provides lifesaving therapeutic benefits for patients with anemia, thalassemia, sickle cell disease, and cancer. Speaking of anemia, it has become more important not only because of the increased prevalence (4.0–7.1% from 2003–2004 to 2011–2012 in United states)[1] but also its association between chronic diseases such as heart failure, fibromyalgia, osteoporosis, chronic inflammation, Alzheimer’s disease, and so on.[2–5] Transfusion is a mainstay in the treatment of anemic patients. It is no surprised that blood transfusions are among the most common procedures performed in Taiwanese hospitals, with a total of 2,149,868 units of red blood cells (RBCs) used in 2015 [6]. Over one in ten hospitalized patients is given a blood transfusion [7].
Blood products are precious and limited resources. Because of population aging and the increasing prevalence of cancer, the demand for blood products has continued to rise over the last two decades. Compared with in 2005, the quantity of RBCs transfused in 2015 increased by 24,085 and 111,860 units in internal medicine divisions and emergency departments, respectively. Blood product availability continues to be a concern. Most blood donors are aged between 30 and 50 years, with the proportion of younger donors being lower than that of older donors. When a severe disaster or pandemic occurs, the shortage of blood products becomes apparent. The Taiwan Blood Services Foundation is raising awareness of the criticality of voluntary blood donation. Moreover, reducing overtransfusion and reviewing inappropriate transfusion practices are essential. The role of patient blood management (PBM) and its clinical application has gradually evolved and gained more attention over the last decades. Meeting patients’ needs individually through optimal evidence-based blood transfusion strategies are at the core of PBM and precision medicine.
Clinicians are accountable for ordering and administering blood products and monitoring transfusion reactions. They are in a key position to detect the signs and symptoms of adverse reactions early. Clinicians follow standard transfusion practices to increase the quality of care. The decision to provide RBC transfusions is based on clinical findings such as signs and symptoms, physical examinations, and laboratory data (e.g., hemoglobin values) [8–10].
Although blood transfusion can be lifesaving and curative, certain risks and complications are associated with the treatment including bloodstream infections, transfusion-related acute lung injury, and coagulation abnormalities. Transfusion can also increase the length of hospital stay, infection rates, complications, and even mortality. Several studies have noted that transfusion does not improve the clinical outcomes of nonbleeding, critically ill patients with anemia. Inappropriate transfusion does not provide any benefits and may even lead to poor outcomes [11], [12].
Numerous guidelines are available to assist practitioners, such as “Clinical Practice Guidelines: Red Blood Cell Transfusion Thresholds and Storage from the American Association of Blood Banks” (AABB) and “the Maximum Surgical Blood Order Schedule.” The Taiwan Blood Services Foundation also provides data on optimal doses and indications of various blood components.
Inappropriate Transfusion
Despite the availability of clinical practice guidelines, significant variability in clinical practice remains. Over half of RBC transfusions may not have been in line with recommended practice. Variability in transfusion practice was identified among hospitals as well as among individual practitioners [13]. This variability indicates that the decision to provide transfusions is based on behavior, individual preferences, rather than scientific data, guidelines, or evidence-based risk versus benefit analysis [14]. Potential barriers between clinical guidelines and physician practices include attitude, lack of self-efficacy, outcome expectancy, and the inertia of previous practice [15].
Avoiding unnecessary blood transfusion not only reduces costs but also improves health-care outcomes [16]. For instance, patients with iron-deficiency anemia (IDA) who received iron supplementation generally had significantly lower hazard ratio for fibromyalgia than those who received blood transfusion alone. On the other hand, iron supplements for hemolytic anemia (HA) may increase the risk of osteoporosis whereas blood transfusions had a lower risk of osteoporosis. Therefore, blood transfusions are not the first line treatment for IDA but are effective for osteoporosis protection in HA.[2, 3] The AABB has education programs and publications for every medical career level worldwide, and most hospitals have their own employee training program. The effectiveness of interventions to reduce physicians’ levels of inappropriate transfusion was identified in several systemic reviews [17–20]. However, no relevant studies have compared the effectiveness and efficiency of existing interventions. The Medical Research Council’s guidance states that the use of evidence and theory-based approaches can assist researchers in understanding the range of possible actions involved in intervention development as well as significantly improve the effectiveness of interventions, thus reducing costs and increasing patients ‘prognosis.[21].
Theory Of Planned Behavior
Ajzen proposed the theory of planned behavior (TPB), a social cognitive theory that links beliefs to behavior [22]. The theory posits that individual behavior is driven by behavioral intention, which is a function of the following three components: attitude, subjective norms, and perceived behavioral control (PBC). Attitude toward behavior can be divided into outcome expectancy and behavioral belief, and subjective norms refer to the perceived social pressure from significant others. PBC relates to factors that can facilitate certain actions, including skills and abilities, time, financial resources, and the cooperation of others. PBC also refers to self-efficacy, which is a person’s belief in their capacity to successfully execute an action.
Various studies have applied the TPB to analyze clinicians’ behavior [23] [24]. Using this theory, numerous studies have described the associations between perceived knowledge, tests of PBM background knowledge, and behavior [25].
Our study assessed the factors that affect clinicians’ behavior in relation to blood transfusion, with two hypotheses proposed. First, the TPB components and knowledge of blood transfusion are associated with clinicians’ behavior toward blood transfusion. Second, the demographic characteristics including education level, hierarchy, and specialty also influence the clinicians’ behavior. The investigation of factors that affect PBM behavior would be valuable and informative for PBM policymakers.